Efficacy and Safety of Naftopidil in Patient With Neurogenic Lower Urinary Tract Dysfunction Not Caused by Benign Prostatic Hyperplasia
Phase of Trial: Phase IV
Latest Information Update: 27 Feb 2017
Price : $35 *
At a glance
- Drugs Naftopidil (Primary) ; Tamsulosin
- Indications Neurogenic bladder
- Focus Therapeutic Use
- 12 Feb 2015 Planned End Date changed from 1 Mar 2015 to 1 Apr 2015 as per ClinicalTrials.gov record.
- 12 Feb 2015 Planned primary completion date changed from 1 Mar 2015 to 1 Apr 2015 as per ClinicalTrials.gov record.
- 12 Feb 2014 New trial record